Is carcinoma in situ a precursor lesion of invasive breast cancer?

International Journal of Cancer

Volumn 135, Issue 7, 2014, Pages 1646-1652

  To, Teresa ^a,b,c   Wall, Claus ^c   Baines, Cornelia J ^c   Miller, Anthony B ^c  

^a HOSPITAL FOR SICK CHILDREN   (Canada)

^b INSTITUTE FOR CLINICAL EVALUATIVE SCIENCES   (Canada)

^c UNIVERSITY OF TORONTO   (Canada)

Author keywords

cancer incidence; carcinoma in situ of the breast; precursor lesion

Indexed keywords

ADULT; ARTICLE; BREAST CARCINOMA; CANCER CLASSIFICATION; CANCER INCIDENCE; CANCER REGISTRY; CANCER SCREENING; CANCER SURGERY; CARCINOGENESIS; CONTROLLED STUDY; DISEASE COURSE; FEMALE; FOLLOW UP; HISTOPATHOLOGY; HUMAN; HUMAN TISSUE; INTRADUCTAL CARCINOMA; INVASIVE CARCINOMA; MALIGNANT TRANSFORMATION; MAMMOGRAPHY; MASTECTOMY; ONSET AGE; PARTIAL MASTECTOMY; PHYSICAL EXAMINATION; PRECANCER; PRIORITY JOURNAL; PROBABILITY;

CANCER INCIDENCE; CARCINOMA IN SITU OF THE BREAST; PRECURSOR LESION;

ADULT; BREAST NEOPLASMS; CARCINOMA IN SITU; CARCINOMA, DUCTAL, BREAST; CARCINOMA, LOBULAR; CASE-CONTROL STUDIES; FEMALE; FOLLOW-UP STUDIES; HUMANS; MIDDLE AGED; NEOPLASM INVASIVENESS; NEOPLASM STAGING; PROGNOSIS; PROSPECTIVE STUDIES;

EID: 84904462561     PISSN: 00207136     EISSN: 10970215     Source Type: Journal    
DOI: 10.1002/ijc.28803     Document Type: Article

References (21)

1. Burstein HJ, Polyak K, Wong JS, et al. Ductal carcinoma in situ of the breast. N Engl J Med 2004; 350: 1430-41.
2. Li CI, Anderson BO, Daling JR, et al. Trends in incidence rates of invasive lobular and ductal breast carcinoma. JAMA 2003; 289: 1421-4.
3. Sprague B, Trentham-Dietz A, Burnside E,. Socioeconomic disparities in the decline in invasive breast cancer incidence. Breast Cancer Res Treat 2010; 122: 873-8.
4. Ernster V, Ballard-Barbash R, Barlow W, et al. Detection of ductal carcinoma in situ in women undergoing screening mammography. J Natl Cancer Inst Mongr 2002; 94: 1546-54.
5. Erbas B, Provenzano E, Armes J, et al. The natural history of ductal carcinoma in situ of the breast: a review. Breast Cancer Res. Treat. 2006; 97: 135-44.
6. Levi F, Randimbison L, Te VC, et al. Invasive breast cancer following ductal and lobular carcinoma in situ of the breast. Int. J. Cancer 2005; 116: 820-3.
7. Kerlikowske K,. Epidemiology of ductal carcinoma in situ. J Natl Cancer Inst Mongr 2010; 41: 139-41.
8. Coldman A, Phillips N,. Incidence of breast cancer and estimates of overdiagnosis after the initiation of a population-based mammography screening program. CMAJ 2013; 185: E492-8.
9. Miller AB, Baines CJ, To T, et al. Canadian National Breast Screening Study 1. Breast cancer detection and death rates among women aged 40 to 49 years. CMAJ 1992; 147: 1458-76.
10. Miller AB, Baines CJ, To T, et al. Canadian National Breast Screening Study. II. Breast cancer detection and death rates among women aged 50 to 59 years [published erratum appears in Can Med Assoc J 1993 Mar 1;148(5): 718] [see comments]. Can. Med. Assoc. J. 1992; 147: 1477-88.
11. Kalbfleisch JD, Prentice RL,. The statisical analysis of failure time data. New York: Wiley, 1980.
12. SAS Institute Inc. SAS/STAT User's Guide, Version 9ed., 2006.
13. Kerlikowske K, Molinaro A, Cha I, et al. Characteristics associated with recurrence among women with ductal carcinoma in situ treated by lumpectomy. J. Natl. Cancer Inst. 2003; 95: 1692-702.
14. Solin LJ, Fourquet A, Vicini FA, et al. Long-term outcome after breast-conservation treatment with radiation for mammographically detected ductal carcinoma in situ of the breast. Cancer Metastasis Rev. 2005; 103: 1137-46.
15. Wilkinson JB, Vicini FA, Shah C, et al. Twenty-year outcomes after breast-conserving surgery and definitive radiotherapy for mammographically detected ductal carcinoma in situ. Ann. Surg. Oncol. 2012; 19: 3785-91.
16. Miller AB, Wall C, Baines C, et al. Twenty five year follow-up for breast cancer incidence and mortality of the Canadian National Breast Screening Study: a randomised screening trial BMJ. 2014;348:g366.
17. Fallowfield L, Francis A, Catt S, et al. Time for a low-risk DCIS trial: harnessing public and patient involvement. Lancet Oncol 2012; 13: 1183-5.
18. Nekhlyudov L, Habel LA, Achacoso N,. Ten-year risk of diagnostic mammograms and invasive breast procedures after breast-conserving surgery for DCIS. J Natl Cancer Inst 2012; 104: 614-21.
19. Tuttle TM, Jarosek S, Habermann EB,. Increasing rates of contralateral prophylactic mastectomy among patients with ductal carcinoma in situ. J Clin Oncol 2009; 27: 1362-7.
20. Punglia R, Schnitt S, Weeks J,. Treatment of ductal carcinoma in situ after excision: would a prophylactic paradigm be more appropriate? J Natl Cancer Inst 2013; 105: 1527-33.
21. Wickerham D, Julian T,. Ductal carcinoma in situ: a rose by any other name. J Natl Cancer Inst 2013; 105: 1521-2.